Cost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy

ConclusionsExtending the treatment of HCV to patients at an early stage of HCV infection is estimated to be cost effective from the perspective of the Italian Healthcare System.

https://link.springer.com/10.1007/s40258-018-0410-x

Source: Applied Health Economics and Health Policy - October 1, 2018 Category: Health Management Source Type: research